| Hui, David S |
NCT05228418: Bridging ED to Outpatient AUD Therapy With Naltrexone |
|
|
| Not yet recruiting | 4 | 20 | US | Naltrexone Pill, naltrexone IM 380mg | Albert Einstein Healthcare Network | Alcohol Use Disorder | 12/24 | 07/25 | | |
NCT04188418: Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients |
|
|
| Active, not recruiting | 3 | 150 | US | Fentanyl Citrate Buccal Tablet, Fentora, Morphine, Physical Performance Testing, Physical Fitness Testing, Physical Function Testing, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | 08/25 | 08/25 | | |
NCT03901001: Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza |
|
|
| Recruiting | 3 | 160 | RoW | sirolimus and oseltamivir, Oseltamivir | Chinese University of Hong Kong | Influenza | 10/25 | 12/25 | | |
NCT03900988: Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia |
|
|
| Recruiting | 3 | 160 | RoW | N-acetyl cysteine, 5% Dextrose | Chinese University of Hong Kong | Influenza | 10/25 | 12/25 | | |
R21NR016736, NCT03021486: Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer |
|
|
| Active, not recruiting | 2/3 | 70 | US | Chlorpromazine, Chlor-PZ, Thorazine, Haloperidol, Haldol, McN-JR-1625, R 1625, R-1625, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI), National Institutes of Health (NIH), National Institute of Nursing Research (NINR) | Advanced Malignant Neoplasm, Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm | 06/21 | 06/25 | | |
NCI-2018-02438, NCT03743649: Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care |
|
|
| Active, not recruiting | 2/3 | 110 | US, RoW | Haloperidol, Haldol, McN-JR-1625, R 1625, R-1625, Lorazepam, Ativan, Placebo, placebo therapy, PLCB, sham therapy, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Delirium, Locally Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm | 12/25 | 12/26 | | |
NCT06336642: Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology |
|
|
| Recruiting | 2/3 | 150 | US | SPOT-ON Early Start, SPOT-ON Delayed Start | M.D. Anderson Cancer Center | Dyspnea | 03/30 | 03/32 | | |
NCT05431595: Managing Agitated Delirium with Neuroleptics and Anti-Epileptics As a Neuroleptic Sparing Strategy |
|
|
| Recruiting | 2/3 | 30 | US | Haloperidol, Chlorpromazine, Chlorpromazine hydrochloride, Thorazine®, Valproate, Depakene, Valproate Acid, Placebo | M.D. Anderson Cancer Center, Cancer Prevention Research Institute of Texas | Delirium, Epileptics, Neuroleptics | 02/27 | 02/27 | | |
NCT05766124: Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE) |
|
|
| Not yet recruiting | 2/3 | 30 | NA | Tissue Plasminogen Activator, Alteplase | Chinese University of Hong Kong | Pleural Infection | 03/28 | 06/28 | | |
NCT01949662: Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer |
|
|
| Active, not recruiting | 2 | 93 | US | Lorazepam, Placebo, Haloperidol decanoate, Questionnaires, Surveys | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Advanced Cancers | 08/16 | 01/26 | | |
NCT02357134: High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer |
|
|
| Active, not recruiting | 2 | 74 | US | Oxygen Therapy, supplemental oxygen therapy, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Respiratory Therapy | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Dyspnea, Malignant Neoplasm | 12/20 | 05/23 | | |
| Active, not recruiting | 2 | 135 | US | Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Placebo, placebo therapy, PLCB, sham therapy, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Dyspnea, Malignant Neoplasm | 05/21 | 12/25 | | |
NCT02932332: High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients |
|
|
| Completed | 2 | 26 | US | High-flow Oxygen, HFOx, Low-flow Oxygen, LFOx, High-flow Air, HFAir, Low-flow Air, LFAir | M.D. Anderson Cancer Center | Cancer | 03/23 | 03/23 | | |
| Completed | N/A | 132 | RoW | Observation, no intervention, No intervention | Chinese University of Hong Kong | Asthma | 12/22 | 12/22 | | |
NCT03043378: Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic |
|
|
| Completed | N/A | 201 | US | Questionnaires, Surveys | M.D. Anderson Cancer Center | Malignant Neoplasms of Independent (Primary) Multiple Sites | 03/23 | 03/23 | | |
NCT05058339: Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer |
|
|
| Completed | N/A | 223 | US | Survey Administration | M.D. Anderson Cancer Center | Advanced Malignant Solid Neoplasm, COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Hematologic Malignancy, Recurrent Malignant Solid Neoplasm | 09/24 | 09/24 | | |
NCT06196034: Genetic Association With Various Severities, Phenotypes and Endotypes of Asthma. |
|
|
| Recruiting | N/A | 2000 | RoW | No intervention | Chinese University of Hong Kong | Asthma | 01/28 | 01/29 | | |
NCT04989556: Technology-Enhanced Palliative Care for Advanced Cancer Patients |
|
|
| Active, not recruiting | N/A | 119 | US | Interview, Palliative Therapy, Comfort Care, PA-Palliative Therapy, palliation, Palliative, Palliative Care, Palliative Treatment, Symptom Management, Symptoms Management, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration | M.D. Anderson Cancer Center | Advanced Malignant Solid Neoplasm | 05/26 | 05/26 | | |
| Enrolling by invitation | N/A | 400 | RoW | Survey | Chinese University of Hong Kong | Pleural Effusion, Tuberculosis, Pleural | 11/24 | 02/25 | | |
NCT04611243: Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19 |
|
|
| Recruiting | N/A | 700 | RoW | third dose vaccination with CoronaVac vaccine, third dose vaccination with BionTech vaccine, Vaccination with Coronavac vaccine, Vaccination with BionTech Vaccine | Chinese University of Hong Kong, The University of Hong Kong, Health and Medical Research Fund | Lung Function, Exercise Capacity, Quality of Life, Covid19 | 08/25 | 02/26 | | |
NCT06563167: Detection and Prediction of Clinically Significant Pneumothorax After Image-guided Transthoracic Lung Biopsy |
|
|
| Not yet recruiting | N/A | 330 | RoW | CXR | Chinese University of Hong Kong | Lung Biopsy | 12/24 | 12/25 | | |
| Recruiting | N/A | 62 | RoW | Mycobacterium tuberculosis (MTB) cell-free DNA (cf-DNA), Mycobacterium tuberculosis PCR | Chinese University of Hong Kong | Tuberculosis, Pleural | 09/24 | 09/25 | | |
NCT05095948: Improving Processes of Cancer Care Delivery at a Comprehensive Cancer Center |
|
|
| Not yet recruiting | N/A | 200 | US | Discussion, Discuss, Electronic Health Record Review, Questionnaire Administration | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Metastatic Malignant Solid Neoplasm | 09/26 | 09/26 | | |
NCT06778746: Use of Biologics for Severe Asthma in Hong Kong |
|
|
| Recruiting | N/A | 360 | RoW | no interventions, No interventions, this is an observational study | Chinese University of Hong Kong | Asthma | 12/25 | 12/26 | | |
NCT04706988: Relationship of Airway Microbiota, Endotype and Phenotype in Adult Asthma |
|
|
| Recruiting | N/A | 140 | RoW | Treatment of asthma according to GINA guideline | Chinese University of Hong Kong | Asthma | 12/24 | 12/24 | | |
NCT05351515: Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient Elastography |
|
|
| Recruiting | N/A | 1000 | RoW | | Chinese University of Hong Kong | Sleep Apnea, Obstructive, Fatty Liver | 01/25 | 01/25 | | |
NCT06796647: ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients |
|
|
| Not yet recruiting | N/A | 100 | RoW | ESAT6/CFP10 skin test | Chinese University of Hong Kong | Tuberculosis (TB) | 02/28 | 08/28 | | |
| Not yet recruiting | N/A | 350 | RoW | | Chinese University of Hong Kong | Tuberculosis, Pleural | 02/26 | 02/26 | | |
NCT05569629: Bronchial Washing Beforeand After Endobronchial Biopsy and Bronchial Brushing |
|
|
| Completed | N/A | 118 | RoW | Bronchial washing before endobronchial biopsy and brushing | Chinese University of Hong Kong | Lung Cancer | 10/23 | 06/24 | | |
NCT06722846: Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study. |
|
|
| Not yet recruiting | N/A | 400 | US | Randomized Case Vignette Study | M.D. Anderson Cancer Center | Health Options, Strategic Care Planning | 08/26 | 08/28 | | |
NCT04639791: To Assess the Management of Patients on Global Initiative of Asthma (GINA) Step 4 and 5 Treatment in Hong Kong |
|
|
| Recruiting | N/A | 500 | RoW | No intervention | Chinese University of Hong Kong | Asthma | 12/25 | 12/25 | | |
NCT05759117: Prospective Evaluation of Patients With Pleural Effusion |
|
|
| Recruiting | N/A | 1000 | RoW | thoracentesis, chest drain insertion | Chinese University of Hong Kong | Pleural Effusion | 03/26 | 03/26 | | |
NCT05825014: Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong |
|
|
| Recruiting | N/A | 100000 | RoW | No intervention | Chinese University of Hong Kong | COPD Exacerbation | 04/26 | 04/27 | | |
NCT05091632: Assessment of Verbal Comprehension and Cognitive Processes in Patients Admitted to the Palliative and Supportive Care Unit |
|
|
| Suspended | N/A | 30 | US | Electroencephalography, EEG, electroencephalogram, Questionnaire Administration | M.D. Anderson Cancer Center | Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Recurrent Malignant Solid Neoplasm | 02/27 | 02/27 | | |
| Szeto, Cheuk Chun |
| Active, not recruiting | 3 | 404 | Europe, Canada, Japan, US, RoW | Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo | Chinook Therapeutics, Inc. | IgA Nephropathy, Immunoglobulin A Nephropathy | 12/26 | 12/26 | | |
| Recruiting | 2 | 48 | RoW | Empagliflozin 10 MG, Jardiance 10mg daily | Chinese University of Hong Kong | End Stage Renal Disease on Dialysis, Peritoneal Dialysis Complication, Sodium-glucose Cotransporter-2 Inhibitor, Residual Kidney Function | 07/26 | 10/26 | | |
NCT05532878: Pharmacokinetics of Apixaban in Peritoneal Dialysis |
|
|
| Recruiting | N/A | 50 | RoW | Apixaban | Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong | Atrial Fibrillation | 12/25 | 03/26 | | |
| Cheung, Peter |
NCT05459909: The Effect of Synbiotic and Diet Modification Among Overweight or Obese Hong Kong Chinese |
|
|
| Active, not recruiting | N/A | 100 | RoW | Synbiotic supplementation, Dietary intervention | Chinese University of Hong Kong | Obesity | 12/23 | 07/24 | | |
| Yan, Bryan P |
EMPA, NCT05556044: Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction |
|
|
| Recruiting | 3 | 200 | RoW | Empagliflozin 10 MG | Chinese University of Hong Kong | Acute Heart Failure | 02/24 | 05/24 | | |
| Terminated | 1/2 | 5 | RoW | YQ23, Matching placebo | New Beta Innovation Limited | Critical Limb Ischemia | 08/23 | 08/23 | | |
| Recruiting | N/A | 376 | Europe, US, RoW | SELUTION SLR™ DEB 014, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities | 06/27 | 07/29 | | |
| Completed | N/A | 200 | RoW | No intervention as this is an observational study | Chinese University of Hong Kong | Thromboembolism | 11/23 | 08/24 | | |
| Recruiting | N/A | 27 | RoW | Electrical Activation Mapping Guided Cardiac resynchronization therapy | Chinese University of Hong Kong | Heart Failure | 12/23 | 03/24 | | |
TQJ230, NCT05548023: Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period |
|
|
| Active, not recruiting | N/A | 500 | RoW | The AngioliteTM Durable Fluoroacrylate Polymer-based Sirolimus-Eluting Stent | Chinese University of Hong Kong | Cardiovascular Diseases | 12/24 | 02/25 | | |
| Recruiting | N/A | 50 | RoW | A Paclitaxel Drug-Coated Balloon | Chinese University of Hong Kong | Myocardial Infarction, Drug-Coated Balloon | 04/24 | 07/24 | | |
| Recruiting | N/A | 50 | RoW | Orsiro Mission, Resolute Onyx | Chinese University of Hong Kong | Percutaneous Intervention | 06/24 | 09/24 | | |
| Recruiting | N/A | 93 | RoW | Electrical Activation Mapping Guided Cardiac resynchronization therapy | Chinese University of Hong Kong | Heart Failure | 08/24 | 12/24 | | |
NCT03356652: Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy |
|
|
| Recruiting | N/A | 93 | RoW | Noninvasive electrical dyssynchrony study, Noninvasive electrical activation, Electrical Activation Mapping, Noninvasive mapping system, ECVUE | Chinese University of Hong Kong | Heart Failure | 08/24 | 08/24 | | |
| Recruiting | N/A | 300 | Europe, US, RoW | SELUTION SLR™ 018 DEB, Plain (Uncoated) Balloon Angioplasty (PTA) | MedAlliance, LLC, NAMSA, Cordis Corporation | Peripheral Arterial Disease, Superficial Femoral Artery Stenosis | 08/25 | 12/29 | | |
| Recruiting | N/A | 300 | RoW | BioFreedom Ultra | Chinese University of Hong Kong | Coronary Artery Disease | 04/28 | 07/28 | | |
NCT05609500: Warfarin Dosage Adjustment Model Analysis Study |
|
|
| Recruiting | N/A | 1200 | RoW | Warfarin dosage adjustment model | Chinese University of Hong Kong, Professor Bryan Ping Yen YAN (byan) | Warfarin | 09/23 | 12/23 | | |
| Not yet recruiting | N/A | 500 | RoW | Standard care | Chinese University of Hong Kong | Heart Failure | 10/27 | 01/28 | | |
| Wong, Patrick |
NCT04598438: Music to Enhance Auditory Encoding in Young Children |
|
|
| Recruiting | N/A | 48 | RoW | Music behavioral early intervention program, Arts and crafts early enhancement program | Chinese University of Hong Kong | Healthy | 10/22 | 03/25 | | |
NCT05455411: Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder |
|
|
| Active, not recruiting | N/A | 112 | RoW | Group-based Parent-implemented Training, Individual-based Parent-implemented Training | Chinese University of Hong Kong | Autism Spectrum Disorder, Autism, Social Communication, Speech Therapy, Parenting | 01/26 | 06/26 | | |
NCT05635760: Parent-implemented Social Communication Treatment in Preschool Children With Autism Spectrum Disorder |
|
|
| Active, not recruiting | N/A | 112 | RoW | Group-based Parent-implemented Social Communication Training, Self-learning-based Parent-implemented Social Communication Training | Chinese University of Hong Kong | Autism, Social Communication, Speech Therapy, Parenting, Autism Spectrum Disorder | 06/25 | 06/26 | | |
| Loong, Herbert Ho Fung |
| Active, not recruiting | 3 | 120 | Europe, Canada, US, RoW | vimseltinib, DCC-3014, Placebo | Deciphera Pharmaceuticals LLC, Deciphera Pharmaceuticals, LLC | Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor, Diffuse, Tenosynovial Giant Cell Tumor, Localized | 08/23 | 07/26 | | |
| Active, not recruiting | 1/2 | 856 | Europe, Canada, Japan, US, RoW | LOXO-292, Selpercatinib, LY3527723 | Loxo Oncology, Inc., Eli Lilly and Company | Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer, Any Solid Tumor | 02/25 | 02/26 | | |
|
|
|
|
|
|
|
| Active, not recruiting | 1/2 | 300 | US, RoW | CAB-AXL-ADC, PD-1 inhibitor | BioAtla, Inc. | Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | 01/25 | 01/25 | | |
| Completed | 1/2 | 132 | Europe, US, RoW | CAB-ROR2-ADC, BA3021, PD-1 inhibitor | BioAtla, Inc., BioAtla Inc. | Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Melanoma, Head and Neck Cancer | 12/24 | 12/24 | | |
| Recruiting | 1/2 | 500 | Europe, Canada, Japan, US, RoW | Oral repotrectinib (TPX-0005), repotrectinib | Turning Point Therapeutics, Inc., Zai Lab (Shanghai) Co., Ltd. | Locally Advanced Solid Tumors, Metastatic Solid Tumors | 02/28 | 02/28 | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Terminated | 1 | 29 | Europe, US, RoW | PBI-200 | Pyramid Biosciences, Pyramid Biosciences, Inc., Pyramid Biosciences | Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor | 07/23 | 07/23 | | |
NCT03906331: Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation |
|
|
| Approved for marketing | N/A | | Europe, Japan, US, RoW | Selpercatinib, LOXO-292, LY3527723 | Eli Lilly and Company, Eli Lilly and Company | Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer, Breast Cancer, Pancreatic Cancer, Papillary Thyroid Cancer, Other Solid Tumors With Evidence of Activating RET Alteration | | | | |
| Lin, Zhi-xiu |
NCT04419584: Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children |
|
|
| Active, not recruiting | 2/3 | 64 | RoW | Modified Qing-Ying Decoction, Identical looking placebo | Chinese University of Hong Kong | Atopic Dermatitis | 12/22 | 05/23 | | |
| Recruiting | 2 | 68 | RoW | COVID Rehab Formula granules, Placebo granules | Chinese University of Hong Kong | Covid19 | 01/23 | 06/23 | | |
NCT04967092: Modified Xiao-Feng Powder for Chronic Urticaria |
|
|
| Recruiting | 2 | 58 | RoW | Modified Xiao-Feng Powder + Antiallergics, Placebo + Antiallergics | Prof. Lin Zhixiu | Chronic Urticaria | 03/23 | 09/23 | | |
NCT04976023: The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis |
|
|
| Completed | 2 | 58 | RoW | Yupingfeng Powder granules, Yupingfeng Powder with variation, Placebo, Placebo granules | Prof. Lin Zhixiu | Allergic Rhinitis | 06/23 | 06/23 | | |
NCT05122702: An Innovative Chinese Herbal Formula for Macular Edema |
|
|
| Recruiting | 2 | 70 | RoW | modified Shenling Baizhu San, Placebo, Placebo granules | Chinese University of Hong Kong | Macula Edema | 07/24 | 01/25 | | |
| Tan, Guangming |
| Recruiting | N/A | 10 | RoW | Symplicity Spyral RENAL DENERVATION (RDN) SYSTEMTM Livewire™ Reflexion™ Catheter | Chinese University of Hong Kong | Hypertension, Renal | 04/23 | 07/23 | | |
| Completed | N/A | 200 | RoW | No intervention as this is an observational study | Chinese University of Hong Kong | Thromboembolism | 11/23 | 08/24 | | |
| Terminated | N/A | 50 | RoW | Percutaneous Balloon Pericardiotomy, balloon pericardiotomy | Chinese University of Hong Kong | Pericardial Effusion Malignant | 01/24 | 09/24 | | |
| Recruiting | N/A | 20 | RoW | JETi Hydrodynamic Thrombectomy System | Abbott Medical Devices | Peripheral Venous Thrombosis, Peripheral Arterial Thrombosis, Peripheral Arteriovenous Thrombosis | 02/25 | 02/25 | | |
NCT05744986: Transcatheter Renal Artery Sympathetic Denervation Observational Study |
|
|
| Recruiting | N/A | 100 | RoW | SYMPICITY Spyral RENAL DENERVATION (RDN) SYSTEMTM | Chinese University of Hong Kong | Hypertension, Renal | 11/24 | 01/25 | | |
| Recruiting | N/A | 500 | RoW | Active pedal plantarflexion (APP) test | Chinese University of Hong Kong, Professor Bryan Ping Yen YAN (byan) | Peripheral Arterial Disease | 05/23 | 12/23 | | |
NCT05609500: Warfarin Dosage Adjustment Model Analysis Study |
|
|
| Recruiting | N/A | 1200 | RoW | Warfarin dosage adjustment model | Chinese University of Hong Kong, Professor Bryan Ping Yen YAN (byan) | Warfarin | 09/23 | 12/23 | | |
| Chau, Pak Chun Janita |
NCT04438291: HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female Adolescents |
|
|
| Completed | N/A | 1340 | RoW | MDL-SHPVP, 30-minute educational video | Chinese University of Hong Kong | HPV Infection, Health Behavior, Health Attitude | 05/24 | 05/24 | | |
| Lin, Zhixiu |
| Not yet recruiting | 2/3 | 140 | NA | Chinese Herbal Medicine granules, Yupingfeng Powder with variation, Placebo, Placebo granules | Chinese University of Hong Kong | Allergic Rhinitis | 08/25 | 10/25 | | |
NCT05980637: Effectiveness and Safety of Shaoyao Gancao Decoction With Addition on the Sleep-related Leg Cramps |
|
|
| Not yet recruiting | 2/3 | 60 | RoW | Shaoyao Gancao Decoction with Addition, SGDA, Placebo | Chinese University of Hong Kong | Sleep-related Leg Cramps | 02/25 | 08/25 | | |
| Recruiting | 2 | 68 | RoW | COVID Rehab Formula granules, Placebo granules | Chinese University of Hong Kong | Covid19 | 01/23 | 06/23 | | |
NCT04967092: Modified Xiao-Feng Powder for Chronic Urticaria |
|
|
| Recruiting | 2 | 58 | RoW | Modified Xiao-Feng Powder + Antiallergics, Placebo + Antiallergics | Prof. Lin Zhixiu | Chronic Urticaria | 03/23 | 09/23 | | |
NCT04976023: The Effects of Using Yupingfeng Powder with Variation for the Treatment of Allergic Rhinitis |
|
|
| Completed | 2 | 58 | RoW | Yupingfeng Powder granules, Yupingfeng Powder with variation, Placebo, Placebo granules | Prof. Lin Zhixiu | Allergic Rhinitis | 06/23 | 06/23 | | |
NCT05209633: Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis |
|
|
| Recruiting | 2 | 20 | RoW | Granules Dendrobii, Dendrobii, Placebo | Chinese University of Hong Kong | Atrophic Gastritis | 01/24 | 08/24 | | |
| Recruiting | 2 | 60 | RoW | Inflammatory skin disease formula, ISDF, Placebo | Chinese University of Hong Kong | Psoriasis | 02/24 | 08/24 | | |
NCT05787327: RCT for Yinqiaosan-Maxingganshitang in the Treatment of COVID-19 |
|
|
| Recruiting | 2 | 96 | RoW | Chinese Herb, CM, Placebo, Plavebo | Chinese University of Hong Kong | COVID-19 | 04/24 | 09/24 | | |
NCT05122702: An Innovative Chinese Herbal Formula for Macular Edema |
|
|
| Recruiting | 2 | 70 | RoW | modified Shenling Baizhu San, Placebo, Placebo granules | Chinese University of Hong Kong | Macula Edema | 07/24 | 01/25 | | |
NCT05499312: An Innovative Chinese Herbal Formula for the Treatment of Gout |
|
|
| Recruiting | 2 | 80 | RoW | HKIIM-KU formula, HKIIM-KU, Placebo | Chinese University of Hong Kong | Gout | 08/24 | 02/25 | | |
| Not yet recruiting | 2 | 76 | NA | Modified Suan ZaoRen Tang-TianWang BuXin Dan, mSZT-TBD, Placebo, Placebo granules | Chinese University of Hong Kong | Insomnia Chronic | 05/26 | 08/26 | | |
NCT05799391: RCT for the Efficacy of Soothing Cream Jel in Improving Upper Limb Pain and Motion |
|
|
| Recruiting | 2 | 70 | RoW | SJC, Soothing cream jel, Placebo | Chinese University of Hong Kong | Upper Extremity Problem | 01/25 | 06/25 | | |
NCT06700408: RCT for the Chinese Medicine in Treating Hypercholesterolemia |
|
|
| Not yet recruiting | 2 | 70 | NA | Dachaihu Decoction combined Erzhiwan with variation, Chinese medicine granules, Placebo granules | Chinese University of Hong Kong | Hypercholesterolemia | 12/26 | 04/27 | | |
NCT05665777: Chinese Medicine for Treating Chronic Pharyngolaryngitis |
|
|
| Recruiting | 2 | 74 | RoW | Qingyan Lihou Decoction, Active treatment, Placebo | Chinese University of Hong Kong | Chronic Pharyngolaryngitis (Disorder) | 01/25 | 07/25 | | |
NCT05815797: Shuiniujiao Dihuang Decoction With Variation for the Treatment of Psoriasis |
|
|
| Not yet recruiting | 2 | 58 | NA | SDD formula, Placebo | Chinese University of Hong Kong | Psoriasis Vulgaris | 04/25 | 10/25 | | |
NCT05754801: Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer |
|
|
| Not yet recruiting | 2 | 172 | NA | Yunzhi Essence, Yunzhi, Placebo | Chinese University of Hong Kong | Cancer, Palliative Care | 03/26 | 09/26 | | |
NCT05613062: Modified Huang-Lian-Jie-Du Decoction (MHLJDD) for Atopic Dermatitis in Children |
|
|
| Recruiting | 1/2 | 20 | RoW | Modified Huang-Lian-Jie-Du Decoction (MHLJDD), Chinese medicine, Placebo | Chinese University of Hong Kong | Atopic Dermatitis | 12/23 | 06/24 | | |
NCT04532697: Use of Gou-Teng to Treat Patients With Mild Cognitive Impairment |
|
|
| Recruiting | N/A | 56 | RoW | Uncaria Rhynchophylla (Gou-Teng), Placebo | Chinese University of Hong Kong | Mild Cognitive Impairment, White Matter Hyperintensity | 03/22 | 09/22 | | |
| Active, not recruiting | N/A | 70 | RoW | Tui-na, Du-Huo-Ji-Sheng-Tang (DHJST), Herbal granules | Chinese University of Hong Kong | Knee Osteoarthritis | 12/22 | 03/23 | | |
| Xu, Daniel |
EMPA, NCT05556044: Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction |
|
|
| Recruiting | 3 | 200 | RoW | Empagliflozin 10 MG | Chinese University of Hong Kong | Acute Heart Failure | 02/24 | 05/24 | | |
| Terminated | 1/2 | 5 | RoW | YQ23, Matching placebo | New Beta Innovation Limited | Critical Limb Ischemia | 08/23 | 08/23 | | |
| Recruiting | N/A | 10 | RoW | Symplicity Spyral RENAL DENERVATION (RDN) SYSTEMTM Livewire™ Reflexion™ Catheter | Chinese University of Hong Kong | Hypertension, Renal | 04/23 | 07/23 | | |
| Recruiting | N/A | 18 | RoW | Electrical Activation Mapping Guided Cardiac resynchronization therapy | Chinese University of Hong Kong | Heart Failure | 08/23 | 12/23 | | |
| Completed | N/A | 200 | RoW | No intervention as this is an observational study | Chinese University of Hong Kong | Thromboembolism | 11/23 | 08/24 | | |
| Recruiting | N/A | 27 | RoW | Electrical Activation Mapping Guided Cardiac resynchronization therapy | Chinese University of Hong Kong | Heart Failure | 12/23 | 03/24 | | |
